Galapagos NV (GLPG)
NASDAQ: GLPG · IEX Real-Time Price · USD
29.51
+0.16 (0.56%)
May 2, 2024, 1:57 PM EDT - Market open
Galapagos NV Employees
Galapagos NV had 1,123 employees on December 31, 2023. The number of employees decreased by 215 or -16.07% compared to the previous year.
Employees
1,123
Change (1Y)
-215
Growth (1Y)
-16.07%
Revenue / Employee
$237,186
Profits / Employee
$209,456
Market Cap
1.95B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,123 | -215 | -16.07% |
Dec 31, 2022 | 1,338 | 29 | 2.22% |
Dec 31, 2021 | 1,309 | 5 | 0.38% |
Dec 31, 2020 | 1,304 | 301 | 30.01% |
Dec 31, 2019 | 1,003 | 278 | 38.34% |
Dec 31, 2018 | 725 | 125 | 20.83% |
Dec 31, 2017 | 600 | 92 | 18.11% |
Dec 31, 2016 | 508 | 73 | 16.78% |
Dec 31, 2015 | 435 | 18 | 4.32% |
Dec 31, 2014 | 417 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Owens & Minor | 22,200 |
Amneal Pharmaceuticals | 7,700 |
Evotec SE | 4,952 |
NeoGenomics | 2,100 |
Twist Bioscience | 919 |
Recursion Pharmaceuticals | 500 |
RxSight | 374 |
GLPG News
- 1 day ago - Galapagos' shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 - GlobeNewsWire
- 27 days ago - Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 - GlobeNewsWire
- 4 weeks ago - Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' Meetings - GlobeNewsWire
- 5 weeks ago - Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board - GlobeNewsWire
- 2 months ago - Galapagos announces full year 2023 results and outlook for 2024 - GlobeNewsWire
- 2 months ago - Galapagos presents at EBMT-EHA annual meeting 2024 - GlobeNewsWire
- 3 months ago - Galapagos completes transaction to transfer Jyseleca® business to Alfasigma - GlobeNewsWire
- 4 months ago - Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. - GlobeNewsWire